# Lantern Pharma Inc.: Form 8-K, filed Aug 3, 2026

- Company: [Lantern Pharma Inc.](/companies/ltrn.md) (CIK 1763950)
- Form: 8-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 21:24 ET
- Period: 2026-08-03
- Accession: 0001493152-26-035864
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1763950/000149315226035864/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1763950/000149315226035864/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1763950/000149315226035864/form8-k.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-035864. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.